1. Introduction
Local hyperthermia therapy has recently become one of the most intensively explored strategies, especially for the treatment of different types of cancer and drug-resistant bacterial infections [
1], which are two of the main health challenges worldwide [
2,
3,
4,
5,
6]. In particular, the administration of local moderate hyperthermia (43–50 °C) has been proven to selectively inhibit the growth and promote the apoptosis of cancer cells, instead of the undesired necrosis, as the healthy tissue is able to resist, due to basic physiological differences between both tissue vasculatures [
7,
8]. Recent studies have shown that when hyperthermia is used as adjunct therapy along with chemotherapy or radiotherapy, the efficacy of the treatment increases without considerably increasing toxicity in healthy tissues [
2,
9]. In the case of a strategy against bacterial infections, certain doses of moderate and ablative (50–55 °C) hyperthermia have been proven, alone or in combination with antibiotics or antimicrobial peptides, to inhibit the growth of drug-resistant bacterial biofilms, affecting their motility and cell-wall integrity [
1,
10,
11,
12]. In this sense, accurate local application of the required levels of hyperthermia must be ensured with thermal doses specifically determined for each case, limiting the area of action of the treatment to the damaged tissues and guaranteeing a minimal impact on the surrounding healthy tissues [
1,
4].
Several technological approaches have been developed for applying local hyperthermia without causing damage to the surrounding tissue, such as radiofrequency ablation, focused ultrasound, laser ablation, and magnetic-mediated hyperthermia (MMH) [
13,
14]. Among them, MMH stands out because of its high efficiency in providing the temperature rise. This hyperthermia is achieved under an external alternating magnetic field (AMF) generator, which induces electrical currents on magnetic nanoparticles situated inside the body in close contact with the targeted region, resulting in the generation of heat [
2,
13]. The use of nanoparticles facilitates locally controlled applications and provides unique properties owing to the high fraction of surface atoms and surface energy, as well as the quantum effects produced by their spatial confinement. Moreover, the large surface-to-volume ratio and small size facilitate their distribution over many binding sites as well as their ability to deeply penetrate tumor tissues [
15]. This strategy provides other advantages, such as the absence of penetration depth limitations or complex wave distortions through tissue boundaries [
16]. The key parameters to be controlled for efficient heating in the MMH are the magnetic nanoparticle properties, size, and materials, and the magnetic field parameters (amplitude and frequency) [
2].
Among the magnetic nanoparticles, those composed of magnetite (Fe
3O
4) or iron oxide (II, III), known as IONPs, have been the most investigated. These nanoparticles can be easily synthesized and functionalized to increase their internalization by target cells. In fact, magnetite-based hyperthermia has already been applied to patients in controlled studies, given its low cytotoxicity and tunable magnetic properties that promote the warming of the cells closest to the IONPs with minimal effect on the surrounding healthy tissue [
15]. In this sense, these IONPs can be incorporated directly into the living tissues of interest but can also be combined with other biomaterials to develop multifunctional devices. For instance, the incorporation of these IONPs on biocompatible and biodegradable scaffolds, designed for bone tissue regeneration purposes, would add the potential of magnetic-mediated hyperthermia against remnant cancer or resistant infections in the damaged tissue area to scaffolds. Currently, research on bone tissue engineering has been intensified towards the obtaining of 3D-printed scaffolds, by additive manufacturing, based on biodegradable polymers such as polylactic acid (PLA), to provide personalized scaffolds with complex morphologies. Three-dimensional printing technology also allows for direct fabrication using an in situ prepared composite mixture combining polylactic acid with other components of interest, such as hydroxyapatite (HA) in bone-related applications [
17]. In this sense, the incorporation of these IONPs in scaffolds obtained by 3D-printing methodologies has been scarcely addressed in the literature [
18]. Several works presented the incorporation of IONPs into PLA scaffolds by using additive fabrication methodologies, such as selective laser sintering, to improve mechanical properties and cell adhesion [
19]. This methodology offers high accuracy. However, it requires high-powered lasers, which increase the cost and the safety requirements. The incorporation of IONPs by 3D printing, known as fused deposition modeling, was recently addressed [
20] in porous calcium silicate/polycaprolactone (PCL) scaffolds. The authors proved that the presence of IONPs together with daily magnetic stimulation increased the differentiation of mesenchymal stem cells to bone regeneration. To fabricate these scaffolds, a paste was previously prepared, requiring previous procedures at high-temperature furnaces and ball milling, before being introduced into the 3D-printing cartridge. Another recent approach [
21] proposes a magnetic 3D-printed scaffold combining PLA with HA, IONPs, and antibiotics against bacterial biofilm and the re-growing of bone tissue. The procedure involves several steps, and the first one is the 3D printing of a PLA filament, continuing with alkaline hydrolysis, washing, and soaking processes (24 h) to load it with nanosized HA, IONPs, and antibiotics.
The present work proposes two easy-to-implement and cost-effective methodologies for the incorporation of IONPs at different concentrations (from 0.10 to 0.50 wt.%) in 3D-printed PLA/HA scaffolds and their thermal behavior evaluation for local magnetic moderate/ablative hyperthermia levels, required against remnant cancer of resistant infections. The methodologies proposed are as follows: (1) The 3D printing of IONPs directly incorporated with the in situ mixture of PLA and HA, generating a uniform distribution inside the scaffold, and (2) the drop coating of the IONPs on the 3D-printed 3D PLA/HA scaffolds, with the IONPs concentrated on one surface of the scaffold. Physicochemical (optical microscopy, SEM/EDS, FT-Raman) and mechanical characterizations (compression tests) of the scaffolds with different IONP concentrations by the two methodologies are presented to confirm the presence of IONPs and evaluate their distribution and influence. Then, a simulation and experimental validation of the induced AMF provided by the planar coil (314 kHz) were carried out to optimize the experimental conditions. The thermal behavior of the scaffolds obtained with different IONP concentrations and by the two proposed methodologies was then presented, and their ability to generate the required moderate (42–50 °C) or ablative (50–55 °C) hyperthermia assessed for AMF exposition times of 120 s. The influence on the thermal behavior of parameters related to the AFM generator, such as the distance of the scaffolds from the planar coil, and the electric-current intensity applied (varied from 90 to 190 A), were also studied, together with the influence of the individual parameters related to the scaffold, such as the IONPs’ concentrations and the distribution of these IONPs (uniformly, 3D-printed or concentrated on the external layer, drop coating). Finally, preliminary viability assays with the MG63 cell line were performed to validate the absence of potential toxins released from the scaffolds.
The Materials and Methods section describes in detail the fabrication methodologies, the compositional contributions of PLA, HA, and IONPs for each methodology, the printer parameters, and the techniques/procedures used for the physicochemical, mechanical, and biological characterization of the scaffolds. The equipment used to generate the alternating magnetic field (AMF) is also detailed in the Materials and Methods section, together with a simulation (and experimental validation) of the 3D distribution of the AMF generated by the setup used, to elucidate the more efficient position in the X-Y plane and the Z-axis to situate the scaffold, in relation to the planar coil. Then, the AMF experimental methodology carried out, situating the scaffolds on the already defined position, is also described. The Results section incorporates the physicochemical, mechanical, and biological characterizations, and the corresponding temperature–time measurements obtained after 120 s of AMF irradiation for both types of scaffolds, varying the intensity (90–190 A) and the IONP contributions (0.20 to 1.00 mg/scaffold).
2. Materials and Methods
2.1. Raw Materials
Natural polylactic acid (PLA) SMARTFIL
® pellets with an oval shape and dimensions of 5.0 mm and 3.5 mm for the major and minor axis, respectively, were purchased from Smart Materials (Jaén, Spain). Their primary properties are listed in
Table 1. Hydroxyapatite (HA) Captal
® ‘R’ (batch P120R) powder with a spherical morphology (average particle size 3.29 µm) was acquired from Plasma-Biotal Limited (Buxton, UK). According to the manufacturers, it presents a Ca:P ratio in the range 1.66–1.72, a crystallinity around 85–95% and a high surface area of typically 6–20 m
2/g. Iron-oxide (III) (Fe
3O
4) nanoparticles (IONPs) with an average particle size of 15 nm in an aqueous suspension of 5 mg/mL were purchased from Sigma-Aldrich (product. number 900043, Merck, Madrid, Spain).
2.2. Scaffolds Fabrication: 3D-Printing and Drop-Coating Procedures
Two methodologies were used to obtain the intended scaffolds. The first implies direct 3D printing for a mixture of the three compounds. For this, the corresponding amount of PLA was first carefully and repeatedly mixed in a Petri dish using a spatula with HA powder in a 5 wt.% of the total mass and different contributions of IONPs: 0.10, 0.20, and 0.50 wt.%. Mixtures free of IONPs (0.00 wt.%) and PLA alone were also prepared to obtain control scaffolds. The contributions of PLA, HA, and IONPs incorporated into the mixtures to the scaffolds and controls are summarized in
Table 2. Once obtained, each single mass was introduced in the 3D-FDM printer hopper (TUMAKER NX Pellet, Irun, Spain) to obtain the 3D-printed PLA/HA scaffolds shaped as disks with dimensions of 8 mm in diameter and 2.5 mm in height (0.1 mm height per layer) with 100% on infill density conditions. The scaffolds were first designed using SolidWorks 2016 software, and the digital data from the designs were then saved as STL files to generate the corresponding G-code sets for 3D printing using the Simplify3D software (4.1.2). The bed temperature of the 3D-FDM printer was maintained at 50 °C using a nozzle with a filament of 0.8 mm and an infill with a rectilinear pattern of an alternating 90° angle from one layer to the overlapped one. The printer had two extruders and two-point temperature controls, which were adjusted to
T1 = 260–265 °C and
T2 = 185–190 °C to favor the printing of the different mixtures, together with the flow rates. The control scaffolds were fabricated at lower temperatures and higher flow rates. The printing parameters used are listed in
Table 3.
The other set of scaffolds was fabricated using a combination of 3D printing and drop coating. The drop-coating technique, in comparison to other techniques such as the use of a combined filament in 3D printing, allows for a better understanding of the heating process, because the generation of heat is precisely located on the coated surface. Using the 3D-printed PLA/HA scaffolds as the base material (95:5 wt.%), a drop of an aqueous suspension of IONPs was placed on top of the upper surface of the scaffolds. To obtain different deposited masses (0.25, 0.50 and 1.00 mg/scaffold), 50 µL of the 5 mg/mL IONP suspension was pipetted onto the upper face of the PLA/HA disks at the required times, followed by a drying process in a laboratory oven at 37 °C for 24 h after each drop deposition. A volume of 50 µL was selected to ensure complete coating of the PLA/HA disk surface (with a nominal diameter of 8 mm).
Table 4 summarizes the set of drop-coated scaffolds and their nomenclature. In
Figure 1, the details of the 3D-FDM printer used are shown together with the Simplify3D Professional Software image of the design, along with the two methodologies followed to incorporate the IONPs into the PLA/HA scaffold: (1) 3D direct printing and (2) drop coating on the already 3D-printed PLA/HA scaffolds.
2.3. Physicochemical Characterization
The global structure of the scaffolds was first analyzed using a stereomicroscope (Nikon SMZ25, Tokyo, Japan), and the surface morphology was analyzed using a scanning electron microscope (SEM; FEI Quanta 200 high-resolution, CACTI, University of Vigo, Vigo, Spain). The samples were first mounted on metal stubs and sputter coated with carbon. The elemental composition was determined by EDS using an Oxford Inca Energy 300 coupled to an SEM microscope (Buckinghamshire, UK). Moreover, FT-Raman spectroscopy was performed to identify the main molecular vibrations and corresponding functional groups using a B&W Tek i-Raman-785S instrument (Metrohm, Herisau, Switzerland) equipped with a BAC 100 probe (785 nm) in the wavenumber range of 250–3250 cm−1 with an incident laser radiation of 340 mW. Young’s moduli of the scaffolds were determined from stress–strain curves (previous conversion to engineering stress and engineering strain) under quasistatic unidirectional compression tests in a tensile bench with a 5 kg load cell (TA.XTPlusC, Texture Technologies Corp. and Stable Micro Systems, Ltd., Godalming, UK) at a crosshead speed of 0.01 mm/s. The compression tool comprised a stainless-steel cylinder with a diameter of 12.7 mm, applied on the top surface of the scaffolds with a maximum workload of 45 N. The results are expressed as the mean values of five measurements for each condition. The instantaneous elastic deformation was calculated from the ratio of the initial height to the height of the sample at each step of the compression test with a sampling frequency of 400 ppp.
2.4. AMF Hyperthermia: Equipment, Experimental Tests and Numerical Simulations
An alternating magnetic field (AMF) generator was used, with a planar coil (five turns with an inner diameter of 10.5 mm and an outer diameter of 62.0 mm) driven by a transistor inverter (EasyHeat RHS 0224, Ambrell Corp., New York, NY, USA) operated at a frequency of 314 kHz and an electric current (EC) between 90 and 190 A. Moreover, the AMF generator and the coil were both cooled by a water-recirculating coolant system (FlowMax 230, MILLER Electric Mfg. Co., Appleton, WI, USA) with an average mass flow of 0.7 g/m
3. The experimental setup is presented in
Figure 2. The heating effect was measured by thermograph images using an infrared thermal-imaging camera (Testo 881, Testo Inc., Titisee-Neustadt, Germany) and a laser-guided infrared pyrometer (CTL, Micro-Epsilon GmbH & Co., Otenburg, Germany).
The setup of the experimental equipment included a simulation of the induced AMF using MATLAB software R2024A. The intention of this simulation is to visualize the distribution and magnitude of the AMF generated specifically in our experimental setup at any point in the space and, with this information, elucidate the most efficient position in the X-Y plane and the Z-axis to situate the magnetic 3D-printed scaffolds (also considering the specific scaffold’s dimensions, shaped as disks 8 mm in diameter, and 2.5 mm in height), in relation to the planar coil used. The experimental setup was modeled through the discretization of the five coils by concentric arrangements of 300 points of the same radius. Subsequently, the Biot–Savart law (an experimental physics law that relates the magnetic field to distance) was computed at each point for an equivalent current of 75 A flowing through the coils, which is a safe current value for the validation equipment. The space around the coils was also divided into a grid of 200 × 200 × 200 points, so that the intensity of the static magnetic field could be calculated for each of the points.
The simulation results were validated by experimental data using a spectrum analyzer (Spectran
® NF-5030, Euscheid, Germany), which senses the real magnetic field intensity in the z-axis of the coil, confirming the same tendency provided by the simulation. The distribution of the AMF obtained, represented in
Figure 3a, indicates that the closed field lines originate from the center point of the planar coil, together with the alternating polarity responsible for producing parasitic currents in the scaffolds and, consequently, remotely generating heat. Moreover, the AFM modulus (mT) simulation, represented in the color map (
Figure 3b) over two perpendicular planes cutting the planar coil on its corresponding axes, clearly situates the maximum AFM modulus at the center point of the coil and in its vertical plane (Z-axis). Therefore, as expected, the scaffolds must be centered on the Z-axis. The maximum values of the AMF modulus obtained under the simulation along the Z-axis, represented in
Figure 3c, against the distance from the center point of the planar coil, gradually decreased with distance, following a decreasing exponential curve. Based on this result, together with the dimensions of the scaffolds and to facilitate handling, the optimal distance for the experiment was set in the range from 10 mm to 24 mm from the planar coil in the z-axis, being preferentially situated at 10 mm or closer to maximize the AMF intensity. As observed in
Figure 3d, experimental values obtained using an electromagnetic field spectrum analyzer followed the same tendency in a decreasing exponential curve (
Figure 3d), but with lower values for the same distance. This can be easily attributed to the always present limitations in a simulation, to exactly reproduce the real conditions as well as the energy losses in the experimental equipment (heat, magnetic permeability, etc.) and the accuracy limitations of the measuring instrument.
With this information, experimental tests were then carried out with the 3D-printed scaffolds for the two proposed methodologies: the 3D-printed and drop-coated scaffold sets. First, temperature measurements were performed for each sample after 120 s of heating while varying the EC flowing through the induction coil and the distance between the surface of the scaffolds and the coil center. The values of the EC were selected to be 90 A, 120 A, and 190 A, while the measured distance from the coil ranged from 9.60 mm to 23.60 mm. A heating time (120 s) was selected to ensure that the thermal conditions reached a steady state and to measure the saturation temperature in each test. Thus, the dependence of heat generation on the IONP concentration and the alternating magnetic field (AMF) strength was assessed using temperature–distance curves obtained for the setup conditions and the composition of the scaffolds. Second, the induction heating process was evaluated within the first 120 s for all the samples, carrying out temperature measurements every 10 s at a fixed distance of 9.60 mm and an EC of 90 A. This approach allows for the representation of temperature–AMF exposure time curves that better describe the heating process of the scaffolds before reaching thermal stability. To obtain parametric equations that can model and predict the transient thermal behavior, the experimental data were fitted to the exponential equation Equation (1), frequently used to model the induction heating of IONPs in aqueous solutions [
22]. Equation (1) is as follows:
This equation is taken directly from Newton’s law of cooling, which describes the rate of heat loss of an object to its surroundings. It states that the rate of heat loss is directly proportional to the temperature difference between the object and its surroundings. The hotter an object is, the faster it will cool down. This law is equivalent for heating: the hotter an object is, the slower it will heat up, where k is a proportionality constant that depends on the characteristics of the object and environment. Moreover, this equation can be used to calculate the final saturation temperature, where t → ∞.
2.5. Biological Response In Vitro: Cytotoxicity Assay
Before the cell assays, a set of scaffolds obtained by the 3D-printing methodology was packed in a laminar flow cabin and sterilized with a direct source of UV light for 20 min on each side. To evaluate the cytotoxicity of the potential release of small particles from the scaffolds, a solvent extraction test [
23] was performed. To obtain the extracts, the corresponding number of disks, with a ratio of 3 cm
2 of material per ml of supplemented growth medium were placed in individual test tubes with the growth medium DMEM (Lonza) supplemented with 10% fetal bovine serum (HyClone) and 1% of a combination of penicillin, streptomycin, and amphotericin B (Lonza), and maintained in shaking conditions at 120 rpm for 24 h at 37 °C. A positive control for cytotoxicity (phenol solution in growth medium, 6.4 g/L) and a negative control for cytotoxicity (the culture medium itself) were also incubated under the same conditions. The negative control of cytotoxicity is defined [
23] as a liquid medium/material proven to not promote any cytotoxic response, as it is the culture medium supplemented with serum. The positive control of cytotoxicity must be a solvent that promotes a reproducible cytotoxic response, mentioning phenol dilutions specifically as one of the possibilities. The purpose of the negative/positive controls is to demonstrate an appropriate test system response. Cells must behave properly, being viable when cultured with culture medium, and not viable when cultured with dilutions of phenol (6.4 mg/mL), to validate the experiment. After the extraction period, the complete volume of the extract (100%) and the controls subjected to the same conditions were recovered, and different dilutions were prepared (50, 30, 10, and 0%) in fresh supplemented culture medium.
A cell suspension (7 × 104 cells/mL) of the human osteosarcoma cell line MG63 (ECACC 86051601) in growth medium was seeded in a 96-well microplate at a volume of 100 μL per well at 37 °C in a humidified atmosphere with 5% CO2. After 72 h of incubation, the medium of the subconfluent cell layer was replaced in each well with the previously prepared extracts. Four replicates per concentration were incubated with cells for 24 h. Cell viability was quantified using the MTS Cell Proliferation Assay Kit (Abcam, Cambridge, UK). This colorimetric assay is based on the MTS tetrazolium compound, which is exclusively reduced by viable cells to generate a colored formazan dye that is soluble in the culture medium. MTS reagent (10 μL) was then added to each well. After 45 min of incubation, the absorbance of the resulting solutions was measured at a wavelength of 490 nm using a microplate spectrophotometer (Bio-Rad, Hercules, CA, USA). Two independent experiments were performed. Wells with the corresponding extract solution without cells were also tested under the same conditions and subjected to the MTS colorimetric test as a blank control to ensure the avoidance of false positives.
2.6. Statistical Analysis
Data were analyzed using GraphPad Prism 10.3.1 (GraphPad Software Inc., San Diego, CA, USA), and the results are represented graphically as the mean ± standard deviation/standard error. The nonparametric Kruskal–Wallis test was used to determine the statistical differences, and a nonparametric Mann–Whitney test was used to perform the paired comparison. Statistical significance was determined to be * (p ≤ 0.05) at the 95% confidence level.
4. Discussion
The present work proposes two new methodologies for the optimal incorporation of IONPs, in mass contribution per scaffold ≤ 1.00 mg, in 3D-printed scaffolds for local hyperthermia therapy applications. The methodologies are as follows: (1) the direct incorporation of the IONPs together with PLA pellets and HA powder in a 3D pellet printer; and (2) the IONPs drop-coated on the already 3D-printed PLA/HA scaffolds were both proven to provide a controlled incorporation of IONPs into the composite scaffolds. Recent works [
30,
31] have proposed the development of polymeric composite magnetic filaments of magnetite nanoparticles (10, 20 wt.%) and pure PLA, for the same purposes. The authors of those works propose the production of the composite filaments before printing the scaffolds. For this, the process begins with the pulverization of the commercial PLA filament, by cutting it into pieces, grinding the pieces to make granules around 5 mm in diameter, then mixing them with the magnetite nanoparticles, followed by a drying stage and the extrusion of the magnetic composite Fe/PLA filament. In the present work, the direct incorporation of the IONPs (15 nm) with the PLA, as commercial oval pellets with dimensions of 5.0 and 3.5 mm in the major and minor axis, respectively, is demonstrated in a 3D pellet printer, wherein the addition of HA powder (5 wt.%, dimensions around average particle size of 3.29 µm) was also carried out to obtain a magnetic composite scaffold for bone-related applications. Moreover, another methodology, the direct drop coating of the IONPs on the already printed 3D PLA/HA scaffolds, is also proposed, given the versatility that this can offer to the clinician. Both methodologies offer more flexibility for preparing an ad hoc composition according to the specific therapeutic treatment.
Moreover, the present work provides the temperature–time curves obtained for each methodology and their parametrization with the corresponding curves of adjustment obtained, which will allow us to control the hyperthermia therapy applied in a more precise way. The required moderate (43–50 °C) and ablative (50–55 °C) hyperthermia therapy against cancer or resistant infections must be provided with complete control, knowing the kinetics of the process in depth, to apply the required high temperature in the exact tissue/area of interest at the precise time required, by altering the surrounding tissues to the least possible degree. In addition, the influence of parameters such as the distance from the planar coil and the EC intensity were also evaluated in the present work, together with the preliminary cytotoxicity evaluation for an osteoblastic-like cell line. Going into detail, a direct measurement of almost 14 °C of cumulative heating was achieved in the scaffolds obtained for the drop-coating methodology (on the surface where the IONPs were concentrated) after 80 s of AMF application (90 A, 314 kHz, coil distance 9.60 mm), in the case of the DC1.00 scaffolds; 1.00 mg/scaffold. The cumulative heating was 7.2 °C for the methodology based on the 3D direct mixing–printing methodology for the same IONP amount (1.00 mg/scaffold); in this case, it was uniformly distributed through the entire scaffold. These specific data indicated that, as expected, high heating efficiency was obtained for the drop coating, as all of the IONPs are concentrated at the heated surface of the scaffold. In this sense, it is important to notice that the AMF frequency used, and the time of application, agreed with previous published works for the same application [
30,
31]. In fact, Nain et al. [
2] evaluated the dependence of the dissipated power on IONP size and magnetic field frequency (up to 500 kHz), obtaining high specific loss power (SLP) values for the IONPs 15 mm in size, the same as the ones used in the present work, subjected to an AMF at a frequency of 330 kHz, with very close values for higher frequencies. In cases where the intention is to heat the entire scaffold, versus just the external surface heated with the drop-coating methodology, the 3D-printing methodology can be applied. In both cases, the contribution in wt.% of IONPs at the scaffold can be easily increased, in addition to potential variations in the distance from the AFM source and other AMF equipment parameters, in the case that higher hyperthermia levels are required. This work opens new possibilities for the incorporation of magnetic hyperthermia therapy through the personalized 3D-printed tissue-engineered scaffolds. Extensive investigations directly focused on a specific in vivo therapeutic application (anticancer, antibiofilm) must be conducted, including simulations of the tissue heat dissipation.